White label ELPA - ClinicalTrials.eu

Study on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment

Recruiting

3 1 1 1
Investigated diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated drugs:
Study Comparing Isotretinoin with Doxycycline, Tretinoin, and Adapalene for Moderate Acne in Patients with Skin of Color

Recruiting

3 1 1 1
Investigated diseases:
- Acne
Investigated drugs:
Study on Pembrolizumab with Chemotherapy for Early-Stage Triple-Negative Breast Cancer in Patients with High TILs

Recruiting

2 1 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
Study of Cytarabine, Daunorubicin, and Clofarabine for Children with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Recruiting

1 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
Study on the Safety and Effectiveness of Abatacept and Daratumumab for Patients with Rheumatoid Arthritis

Recruiting

1 1 1 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- Abatacept
- Daratumumab
Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

Recruiting

2 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
- Zirconium (89Zr) Crefmirlimab Berdoxam
Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

Recruiting

3 1 1 1
Investigated diseases:
- Pulmonary hypertension
Investigated drugs:
Study on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations

Recruiting

2 1 1 1
Investigated diseases:
- Breast cancer metastatic
Investigated drugs:
- Elacestrant Dihydrochloride
- Olaparib
Study on Beta-Blockers for Patients with Takotsubo Syndrome: Evaluating Selective, Non-Selective, and Alpha-Beta Blocking Agents

Recruiting

3 1 1 1
Investigated diseases:
- Cardiac failure acute
- Stress cardiomyopathy
Long-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001

Recruiting

3 1 1
Investigated diseases:
- Duchenne muscular dystrophy
Investigated drugs:
- Delandistrogene Moxeparvovec

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies